Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Miguel wants to get the virus under control now, so he can minimise the impact of HIV on his lifestyle.
MIGUEL
28 years old | Newly diagnosed
- Professional photographer with a busy work and social life. Currently dating
- Diagnosed following routine testing
- Travels frequently, so wants to carry a discreet medication and as few pills as possible
- Overwhelmed by the amount of information he has seen and heard on HIV
MEDICAL HISTORY
- Viral load 463,000 copies/mL
- CD4+T-cell count 390 cells/mL3
- Smoker
- No current medications
TREATMENT GOALS
- To feel confident that the HIV virus is well controlled, so he can continue leading a normal life, with minimal side effects
- Has heard about U=U and wants to know more, as he is conscious of transmitting HIV
~3 in 5
people living with HIV are concerned about the long-term side effects of HIV medication (n=1,114/1,841)*7
Carlos is considering how to maintain good health in the coming years, whilst remaining undetectable.
CARLOS
43 years old | Diagnosed 16 years ago
Virologically suppressed on DTG+TDF/FTC
- Engaged with his health and is open to taking fewer medicines if his viral load remains undetectable.
- Concerned about the long-term effects of HIV medications.
- Conscious that PLHIV are prone to developing comorbidities
MEDICAL HISTORY
- Previously treated with DTG/ABC/3TC
- Hepatitis B negative
- Family history of high cholesterol
TREATMENT GOALS
- To gain control of his health with an effective treatment that he can tolerate
- To work with his physician to make changes to his lifestyle that support his future
~5 in 10
people living with HIV want a treatment that has less impact on their body in the long-term (n=1,123/2,389)*7
Nikki wants to be involved in her health decisions, so she can get ahead and shape her future.
NIKKI
60 years old | Diagnosed 17 years ago
Virologically suppressed on BIC/FTC/TAF
- Hairdresser, who is feeling empowered and secure after recently entering a new relationship
- Her busy routine means she has missed some medical appointments in the past
- Considering her future goals and long-term health
MEDICAL HISTORY
- Previously treated with DTG+ TDF/FTC
- Family history of high cholesterol
TREATMENT GOALS
- To be more proactive in her overall health
- To discuss the impact her recent weight changes have had on her appearance and self-esteem
- To discuss her treatment options now as she plans for the future
~6 in 10
people living with HIV would like to be more involved in decisions about their HIV treatment (n=1,556/2,389)*7
Christopher is concerned about how his HIV medication is affecting his body as he gets older.
CHRISTOPHER
51 years old | Diagnosed 14 years ago
Virologically suppressed on BIC/FTC/TAF
- Financial analyst in a settled relationship
- Since turning 50 and being diagnosed with high cholesterol, he has been trying to live a healthy lifestyle
- Assumes his treatment is 'as good as it gets', but still worries about how many medications he's taking
- Reliant on, and trusting of, his doctor's treatment recommendations
MEDICAL HISTORY
- Gaps in his early treatment history
- On medication to manage high cholesterol and pre-diabetes
TREATMENT GOALS
- To continue enjoying his life with his partner and friends, whilst remaining undetectable
- To minimise the impact managing HIV has on his health, and other conditions, as he ages
~6 in 10
people living with HIV are concerned about taking more medicines as they grow older (n=1,195/2,112) - but not all will voice this in the consultation*7
Learn more about Dovato and why Dovato is a good option for patients like Miguel, Carlos, Nikki and Christopher
Footnotes:
*Data from Positive Perspectives, one of the largest global HIV patient-reported surveys to date. conducted between April 2019 and January 2020 - 2.389 participants from 25 countries were asked to rate their own health, how Living with HIV impacts their lives and affects their outlook on the future, as well as examining new Interactions and relationships with physicians and their experiences with ART.7
References:
- Cahn P et al. AIDS 2022; 36(1): 39-48.
- Ciccullo A et al. JIADS 2021; 1-14.
- De Wit S et al. J Acquir Immune Defic Syndr 2024. 96(2): 156-160.
- DOVATO. Summary of Product Characteristics. July 2024.
- Maggiolo F et al. BMC Infect Dis 2022; 22(1): 782.
- Taramasso L et al. AIDS Patient Care STDS 2021; 35(9): 342-353.
- ViiV Healthcare. Positive Perspectives study, wave 2 results report. Available at: https://viivhealthcare.com/content/dam/cf-viiv/viivhealthcare/en_GB/files/pp2-global-report-2021-update-031221.pdf. Accessed Aug 2025.
POM. Further information is available from GlaxoSmithKline (Ireland) Ltd.
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255 or via online form https://gsk.public.reportum.com.
Dovato is a registered trade mark of the ViiV Healthcare group of companies or its licensor.
PM-IE-DLL-WCNT-250001 | Date of Preparation: August 2025
